Summary
During the 1960s, it was suggested that, at least in clinical stage I disease, simple mastectomy or even wide excision, plus radiotherapy to the breast and gland fields resulted in the same distant recurrence rate and survival as the orthodox radical operation. It was thought that local control of the disease was not important in terms of ultimate prognosis and it was felt that minimal surgery incurred no penalty. It was forecast that breast cancer would soon be treated by radiotherapy alone, possibly even without removal of the tumour.
Four developments have materially affected the situation.
-
1.
It has been shown that assays of hormone receptors should be carried out on all primary tumours.
-
2.
In clinical stage II disease, it has been demonstrated that restricted surgery results in a penalty in terms of distant recurrence and survival.
-
3.
It is now realised that the number of involved axillary lymph nodes must be known to evaluate future prognosis.
-
4.
Adjuvant chemo or endocrine therapy have proved to be effective in treating patients with heavy axillary node involvement.
These developments mean that the effective treatment of early breast cancer must entail removal of the tumour, achieve local control of disease and include axillary node dissection. Currently, only the modified radical mastectomy effectively equates with these three aims. Nevertheless, it is possible that tumour excision, irradiation to the tumour bed and breast, and axillary node dissection would achieve the same object whilst conserving the breast.
References
Halsted WS: The results of radical operations for cure of cancer of the breast performed at the Johns Hopkins Hospital. Ann Surg 20: 497, 1894.
McWhirter R: The value of simple mastectomy and radiotherapy in the treatment of cancer of the breast. Br J Radiol 21: 252, 599–610, 1948.
Brinkley, Diana and Haybittle JL: Treatment of stage II carcinoma of the female breast. Lancet ii: 291–295, 1966.
Kaae S and Johansen H: Simple vs radical mastectomy in primary breast cancer.In APM Forrest and PB Kunkler (eds): Prognostic Factors in Breast Cancer. E & S Livingstone, Edinburgh and London, 1978, pp 93–102.
Fisher B, Montague Eleanor, Redmond Carol, Barton B, Borland Donna, Fisher ER, Deutsch M, Schwarz G, Margolese R, Donnegan W, Volk H, Konvolinka C, Gardner B, Cohn Jr I, Lesnick G, Cruz AB, Lawrence W, Nealon T, Butcher H, Lawton R (and other NASBP investigators): Comparison of radical mastectomy with alternative treatments for breast cancer. A first report of results from a prospective randomised clinical trial. Cancer 39: 2827–2839, 1977.
Mustakallio S: Treatment of breast cancer by tumour extirpation and roentgen treatment instead of radical operation. J Fac Radiol 6: 23–26, 1954.
Crile G: treatment of breast cancer by local excision. Am J Surg 109: 400–403, 1965.
Atkins Sir Hedley, Hayward JL, Klugman DJ, Wayte AB: Treatment of early breast cancer — a report after ten years of a clinical trial. Br Med J 2: 423–429, 1972.
McGuire WL, Horwitz KB, Pearson OH, Segaloff A: Current status of estrogen and progesterone receptors in breast cancer. Cancer 39: 2934–3947, 1977.
Bonadonna G, Brusamalino E, Valagussa P, Russi A, Brugnatelli L, Brambilla C, De Lena M, Tancini G, Baietta E, Musumeci R, Veronesi U: Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 294: 406–410, 1976.
Meakin JW, Allt WEC, Beale FA, Brown TC, Bush RS, Clarke RM, Fitzpatrick PJ, Hawkins NV, Jenkin RDT, Pringle JF, Reid JG, Rider WD, Hayward JL, Bulbrook RD: Ovarian irradiation and prednisone therapy following surgery and radiotherapy for carcinoma of the breast. CMA Journal 120: 1221–1229, 1979.
Fisher ER, Gregorio RM, Fisher B: The pathology of invasive breast cancer. Cancer 36: 1–85, 1975.
Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP: Management and survival of female breast cancer: results of a national survey by the American College o surgeons. Cancer 45: 2917–2924, 1980.
Davies GC, Millis Rosemary R, Hayward JL: Assessment of axillary lymph node status, Ann Surg 192: 148–151, 1980.
Høst H, Brennhoud IO: The effect of postoperative radiotherapy in breast cancer. Int J Radiat Oncol Biol Phys 2: 1061–1067, 1977.
Lipsett MB: Postoperative radiation for women with cancer of the breast and positive axillary lymph nodes: should it continue? New Eng J Med, 112–114, 1981.
Calle R, Schlienger P, Vilcoq RJ: Place et limites des therapeutiques a visee conservatrice des epitheliomas mammaires. Bull Cancer 64: 633, 1977.
Harris JR, Levene MB, Hellman S: The role of radiation therapy in the primary treatment of carcinoma of the breast. Sem Onc 5: 403–416, 1978.
Pierquin B, Baillet F, Wilson JF: Radiation therapy in the management of primary breast cancer. Am J Roentgenol 127: 645–648, 1976.
Veronesi U, Banfi A, Saccozzi R, Salvadori B, Zucali R, Uslenghi C, Greco M, Luini A, Rilke F, Sultan L: Conservative treatment of breast cancer: a trial in progress at the cancer Institute of Milan. Cancer 39: 2822–2826, 1977.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hayward, J. The surgeon's role in primary breast cancer. Breast Cancer Res Tr 1, 27–32 (1981). https://doi.org/10.1007/BF01807888
Issue Date:
DOI: https://doi.org/10.1007/BF01807888